Celanese Corporation · NYSE:CE
Celanese — Investor Day (March 2021)
16 slides from Celanese's investor day presentation, Mar 25, 2021
Slide 1: Disclosures: Forward-Looking Statements
Disclosures Forward-Looking Statements This presentation contains "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not hi
Slide 2: 2021 Investor Day
2021 Investor Day March 25, 2021
Slide 3: Welcome
Welcome facenece Lori Ryerkerk
Slide 4: Agenda
2 Welcome & Introduction Lori Acetyl Chain (AC) John Engineered Materials (EM) Tom Break Acetate Tow (AT) Lori Sustainability Lori Financial Excellence Scott Wrap Up Lori Break Question & Answer Session Lori Ryerkerk Chairman & CEO Tom Kelly SVP, Engineered Materials Scott Richardson Chief Financial
Slide 5: Collectively focused on delivering value for shareholders
…collectively focused on delivering value for shareholders Everything we do starts with our people… Celanese Values employees shareholders safety customers communityquality 3 ~ Celanese ~ Celanese
Slide 6: Commercial Excellence Enhanced to lift foundational earnings power
Commercial Excellence Enhanced … to sustainably lift the foundational earnings power of Celanese We have been on a path this decade… Competitive Positions & Financial Health Established 2011 2012 2013 2014 Differentiated Business Models Implemented 2015 2016 2017 2018 2019 2020 $4.51 $4.07 $4.50 $5.
Slide 7: Decisive actions amid 2020 pandemic
14% lower Chinese acetic acid pricing lower Engineered Materials affiliate earnings higher turnaround expense 27% lower Q2 Engineered Materials volume … proved the resiliency of our earnings power and positioned us for recovery Decisive actions amid 2020 pandemic… 1 Headwinds versus 2019 2020 Action
Slide 8: Positioned to drive continued shareholder value
Positioned to drive continued shareholder value Total Shareholder Return (February 28, 2011 - February 28, 2021) S&P 500 253% 161% Celanese Avg. Annual TSR 16.1% 13.9% 11.3% Celanese S&P 500 DJUSCH Index 6 Performance has delivered leading total shareholder return 296% DJUSCH Index ~ Celanese ~ Cela
Slide 9: Slide 9
Slide 10: Themes: Focusing our unique business models to win in key end markets
1 Themes you will hear today 8 FOCUSING OUR UNIQUE BUSINESS MODELS TO WIN IN KEY END MARKETS… ENGINEERED MATERIALS ACETYL CHAIN ACETATE TOW Dedicated growth programs Aligning early with industry winners Subsegments with differentiated growth Driving differentiation in downstream products Alternative
Slide 11: Themes: Transforming our approach to productivity
2 Themes you will hear today TRANSFORMING OUR APPROACH TO PRODUCTIVITY … PROCESS AUTOMATION DATA & ANALYTICS SUPPLY CHAIN NETWORK Supply chain optimization tools Customer experience solutions Analytics & predictive forecasting Artificial intelligence for business decisions Regional production locali
Slide 12: Themes: Driving greater sustainability
SUPPLY CHAIN NETWORK 3 Themes you will hear today DRIVING GREATER SUSTAINABILITY... ENVIRONMENTAL SOCIETAL COMMERCIAL Energy & resource efficiency Climate change Diversity, equity & inclusion Community partnerships Sustainable feedstocks End-of-life product solutions ...consistent with our values an
Slide 13: Themes: Enhancing cash generation and capital deployment
4 Themes you will hear today ENHANCING OUR CASH GENERATION AND CAPITAL DEPLOYMENT... ORGANIC INVESTMENT INORGANIC INVESTMENT CASH TO SHAREHOLDERS High-return, capital-efficient expansions Productivity enhancing projects Attractive M&A opportunity sets Joint venture optimization Dividend growth Stead
Slide 14: Multiplying our momentum
Multiplying our momentum… …to deliver double-digit earnings per share growth annually Adjusted Earnings Per Share 2015 2016 2017 2018 2019 2020 2021F 2022F 2023F $6-8 $8-10 $11-14 3 2 1 4 Winning in key end markets Transforming our productivity Driving greater sustainability Enhancing our capital de
Slide 15: Multiplying Our Momentum
Slide 16: Slide 16